Multiple Myeloma | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Rising Tide - Zometa in Chondrosarcoma (JAH)

Cancer Internal Medicine Multiple Myeloma Sarcoma Adult Subjects Female Subjects Male Subjects

The purpose of this single arm open label phase 1b clinical study is to see what effect zoledronic acid has on tumors in patients with resectable any grade chondrosarcoma prior to surgery.

Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab in High-risk Smoldering Multiple Myeloma (SMM)

Cancer Internal Medicine Multiple Myeloma Adult Subjects Female Subjects Male Subjects

The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival (PFS) compared with active monitoring in participants with high-risk smoldering multiple myeloma (SMM).